Zobrazeno 1 - 10
of 215
pro vyhledávání: '"FC Bidard"'
Autor:
C Cheneau, S Barthier, J Lemonnier, Fabrice Andre, C Dubot, L Teixeira, A Escande, T De La Motte Rouge, T Petit, L Arnould, Laurent Arnould, Suzette Delaloge, Jerome Lemonnier, A Marti, L Stefani, F Berger, C Levy, P Barthelemy, S Nguyen, M Gardner, A Lortholary, François-Clément Bidard, J Plaza, L Joly, Thibault de la Motte Rouge, F Andre, I Bièche, C Alleaume, R Sabatier, B Lucas, Ivan Bieche, O Derbel, L Venat-Bouvet, F Del Piano, Florian Clatot, Anne-Claire Hardy-Bessard, Frédérique Berger, Margaux Marce, Thomas Bachelot, Anne Pradines, Jean-Luc Canon, Sandrine Marques, M Achille, H Ammarguellat, O Arsene, T Bachelot, C Bernard-Marty, F-C Bidard, N Bonichon-Lamichhane, N Bonnin, R Bouaita, A Boudrant, V-A Brunel, C Chakiba, F Clatot, F Dalenc, A De Gramont, L Deiana, C Delbaldo, V Delecroix, H Desclos, V D'Hondt, N Dohollou, J-M Ferrero, C Foa, J-S Frenel, C Garnier Tixidre, D Genet, O Gisserot, M Gozy, C Greilsamer, J Grenier, F Guinet, A-C Hardy-Bessard, J-P Jacquin, E Lachaier, S Ladoire, A-P Laurenty, R Le Scodan, N Leduc, E Legouffe, C Levache, F Lorchel, N Marques, J Medioni, A Melis, D Mille, D Mollon, L Moreau, I Moullet, M-A Mouret-Reynier, A Najem, H Orfeuvre, J-F Paitel, B Pistilli, C Riedl, P Soulie, D Spaeth, F Trouboul, C Valmar, H Vegas, A Zannetti, FC Bidard, S Delaloge, A Pradines, JL Canon, S Marques
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction The combination of a CDK4/6 inhibitor with an aromatase inhibitor (AI) has recently become the gold standard for AI-sensitive first line treatment of oestrogen receptor-positive (ER+) HER2-negative (HER2−) advanced breast cancer. Howev
Externí odkaz:
https://doaj.org/article/8faf6bbc845f4ceeb90674dd08e198da
Autor:
Vincent Servois, Aurore Rampanou, Pascale Mariani, Fc Bidard, Jordan Madic, Maud Milder, Laurence Desjardins, M-H Stern, Sophie Piperno-Neumann, Olivier Lantz, Nathalie Cassoux
Publikováno v:
Acta Ophthalmologica. 91
Purpose CtDNA can be detected in the plasma of MUM pts using a real-time PCR based on the pyrophosphorolysis-activated polymerization (bi-PAP) targeting the most frequent GNAQ and GNA11 mutations present in 85% of UM (Madic et al, 2012). Methods May
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08541f367e7f2ebe02d76be04936d2a7
https://doi.org/10.1111/j.1755-3768.2013.4442.x
https://doi.org/10.1111/j.1755-3768.2013.4442.x
Autor:
Piscuoglio S, Ck, Ng, Mp, Murray, Guerini-Rocco E, Lg, Martelotto, Fc, Geyer, Fc, Bidard, Berman S, Nicola Fusco, Ra, Sakr, Eberle C, De Mattos-Arruda L, Gs, Macedo, Akram M, Baslan T, Hicks J, Ta, King, Brogi E, Norton L, Weigelt B
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8df82acb65ab4defb80384bfc7ad8718
http://europepmc.org/abstract/med/26960396
http://europepmc.org/abstract/med/26960396
Autor:
T André1, C Tournigand2, L Mineur3, R Fellague-Chebra4, M Flesch5, M Mabro6, M Hebbar7, S Postel Vinay1, FC Bidard1, C Louvet2, A de Gramont2
Publikováno v:
Annals of Oncology. Jan2007, Vol. 18 Issue 1, p77-81. 5p.
Autor:
Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Centre and Clinical Cancer Genomics Program, BC Cancer, Vancouver, British Columbia, Canada., Litiere S; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Bidard FC; Department of Medical Oncology, Institut Curie, Université Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France., Cabel L; Department of Medical Oncology, Institut Curie, Université Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France., Dyrskjøt L; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Karlovich CA; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Pantel K; Department of Tumor Biology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Petrie J; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Philip R; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Andrews HS; Friends of Cancer Research, Washington, District of Columbia., Vellanki PJ; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Tolmeijer SH; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Villalobos Alberu X; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Alfano C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Bogaerts J; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Toledo RA; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., de Vries EGE; University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Seymour L; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada., Laurie SA; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada., Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Nov 15; Vol. 30 (22), pp. 5034-5041.
Autor:
Rodrigues M; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France.; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France., Ramtohul T; Department of Radiology, Institut Curie, PSL Research University, Paris, France., Rampanou A; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Department of Translational Research, Institut Curie, Paris, France., Sandoval JL; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Department of Translational Research, Institut Curie, Paris, France., Houy A; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France., Servois V; Department of Radiology, Institut Curie, PSL Research University, Paris, France., Mailly-Giacchetti L; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France., Pierron G; Somatic Genetic Unit, Department of Genetics, Institut Curie, PSL Research University, Paris, France., Vincent-Salomon A; Department of Pathology, Institut Curie, PSL Research University, Paris, France., Cassoux N; Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France., Mariani P; Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France., Dutriaux C; Dermatology Department, Hôpital Saint André Centre Hospitalier Universitaire, Bordeaux, France., Pracht M; Medical Oncology Department, Centre Eugène Marquis, Rennes, France., Ryckewaert T; Medical Oncology Department, Oscar Lambret Center, Lille, France., Kurtz JE; Department of Medical and Surgical Oncology & Hematology, ICANS, Strasbourg, France., Roman-Roman S; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France.; Department of Translational Research, Institut Curie, PSL Research University, Paris, France., Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France., Bidard FC; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France.; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Department of Translational Research, Institut Curie, Paris, France.; UVSQ, Paris-Saclay University, Saint Cloud, France., Stern MH; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) team, Institut Curie, PSL Research University, Paris, France. marc-henri.stern@curie.fr., Renault S; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Department of Translational Research, Institut Curie, Paris, France. shufang.renault@curie.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 14; Vol. 15 (1), pp. 8851. Date of Electronic Publication: 2024 Oct 14.
Autor:
Neven P; Universitair Ziekenhuis Leuven, Leuven, Belgium., Stahl N; Helios Kliniken Schwerin, Schwerin, Germany., Vidal M; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón Instituto de Investigacion Sanitaria Gregorio Marañon, CIBERONC, Universidad Complutense, Madrid., Madrid, Spain., Kaufman PA; University of Vermont Cancer Center, Burlington, VT, United States., Harbeck N; University of Munich, Munich, Germany., Hunt KK; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Carter S; Baylor College of Medicine, United States., Bidard FC; Institute Curie, Paris, France., Fasching PA; Universitätsklinikum Erlangen, Erlangen, Germany., Aftimos P; Institut Jules Bordet - Université Libre de Bruxelles, Brussels, Belgium., Wheatley D; Royal Cornwall Hospital Trust, Truro, United Kingdom., Hamilton E; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, United States., Aft R; Washington University in St. Louis, St. Louis, United States., Kulkarni S; Northwestern University, Chicago, IL, United States., Schmid P; Barts Cancer Institute, London, United Kingdom., Bhave M; Emory University, Atlanta, GA, United States., Ismail-Khan R; Eli Lilly and Company, Indianapolis, IN, United States., Karacsonyi C; Eli Lilly and Company, Indianapolis, IN, United States., Estrem ST; Eli Lilly and Company, Indianapolis, IN, United States., Nguyen B; Memorial Sloan Kettering Cancer Center, New York, United States., Ozbek U; Eli Lilly and Company, Indianapolis, IN, United States., Yuen E; Eli Lilly and Company, United States., Rodrik-Outmezguine V; Eli Lilly and Company, Indianapolis, IN, United States., Ciruelos E; Hospital Universitario 12 De Octubre, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.
Autor:
Seban RD; Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210, Saint-Cloud, France. romain.seban@gmail.com.; Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm U1288, PSL University, Institut Curie, Paris Saclay University, 91400, Orsay, France. romain.seban@gmail.com., Champion L; Department of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210, Saint-Cloud, France.; Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm U1288, PSL University, Institut Curie, Paris Saclay University, 91400, Orsay, France., De Moura A; Department of Medical Oncology, Institut Curie, 92210, Saint-Cloud, France., Lerebours F; Department of Medical Oncology, Institut Curie, 92210, Saint-Cloud, France., Loirat D; Department of Medical Oncology, Institut Curie, 75005, Paris, France., Pierga JY; Department of Medical Oncology, Institut Curie, Université Paris Cité, 75005, Paris, France.; Circulating Tumor Biomarkers Laboratory, INSERM CIC BT-1428, Institut Curie, Paris, France., Djerroudi L; Department of Pathology, Institut Curie, 75005, Paris, France., Genevee T; Department of Pharmacy, Institut Curie, 92210, Saint-Cloud, France., Huchet V; Department of Nuclear Medicine, Institut Curie, 75005, Paris, France., Jehanno N; Department of Nuclear Medicine, Institut Curie, 75005, Paris, France., Bidard FC; Department of Medical Oncology, Institut Curie, UVSQ/Paris-Saclay University, 92210, Saint-Cloud, France.; Circulating Tumor Biomarkers Laboratory, INSERM CIC BT-1428, Institut Curie, Paris, France., Buvat I; Laboratoire d'Imagerie Translationnelle en Oncologie, Inserm U1288, PSL University, Institut Curie, Paris Saclay University, 91400, Orsay, France.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Oct 07. Date of Electronic Publication: 2024 Oct 07.
Autor:
Bardia A; University of California Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona, Spain; and IOB Madrid, Hospital Beata Maria Ana, and Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain., Bidard FC; Institut Curie, Paris and Saint Cloud, France., Neven P; Universitaire Ziekenhuizen (UZ)-Leuven Cancer Institute, Leuven, Belgium., Garcia-Sáenz J; Instituto de Investigación Sanitaria Hospital Clinico San Carlos (IdISSC), Madrid, Spain., Aftimos P; Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium., O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas., Lu J; Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois., Tonini G; Menarini Group, Florence, Italy., Scartoni S; Menarini Group, Florence, Italy., Paoli A; Menarini Group, Florence, Italy., Binaschi M; Menarini Group, Florence, Italy., Wasserman T; Menarini Group, Florence, Italy., Kaklamani V; University of Texas Health Sciences Center, San Antonio, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4299-4309.
Autor:
Djerroudi L; Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France; Institut Curie, Women's Cancer Institute, PSL University, INSERM U830, Stress and Cancer Laboratory, Paris, France., Bendali A; Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France., Fuhrmann L; Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France., Benoist C; Institut Curie, Women's Cancer Institute, PSL University, Clinical Bioinformatics, Paris, France., Pierron G; Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France., Masliah-Planchon J; Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France., Kieffer Y; Institut Curie, Women's Cancer Institute, PSL University, INSERM U830, Stress and Cancer Laboratory, Paris, France., Carton M; Institut Curie, PSL University, Department of Statistics, Paris, France., Tille JC; Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France; Hopitaux Universitaires de Geneve, Department of Pathology, Geneva, Switzerland., Cyrta J; Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France., Ramtohul T; Institut Curie, Women's Cancer Institute, PSL University, Department of Radiology, Paris, France., Bonneau C; Institut Curie, Women's Cancer Institute, Université de Versailles Saint-Quentin-en-Yvelines, Department of Surgery, Saint-Cloud, France., Caly M; Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France., Renault V; Institut Curie, Women's Cancer Institute, PSL University, Clinical Bioinformatics, Paris, France., Bidard FC; Institut Curie, Women's Cancer Institute, Université de Versailles Saint-Quentin-en-Yvelines, Department of Medical Oncology, Saint-Cloud, France., Mechta-Grigoriou F; Institut Curie, Women's Cancer Institute, PSL University, INSERM U830, Stress and Cancer Laboratory, Paris, France., Vincent-Salomon A; Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France. Electronic address: anne.salomon@curie.fr.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Oct; Vol. 37 (10), pp. 100570. Date of Electronic Publication: 2024 Jul 16.